Security key
79400X404
Salarius Pharmaceuticals, Inc. - COMMON STOCK (SLRX)
CUSIP: 79400X404
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 116,491
- Total 13F value
- $103,798
- Share change
- +52,316
- SEC-reported price per share
- $0.90
- Number of holders
- 14
- Value change
- +$48,480
- Number of buys
- 9
- Number of sells
- 3
Report period
Q2 2025
Institutions
14
Top holders
10
SLRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Decoy Therapeutics Inc. SEC filings
Decoy Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 79400X404
Recent filing periods:
Ownership snapshot
Top reported holders of SLRX - Salarius Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
UBS Group AG
Disclosed value leader
UBS Group AG
Comparable rows
0/11
Latest evidence
31 Mar 2025
13F
3/4/5
Highest disclosed value: $25,495
11 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
UBS Group AG has the largest disclosed position value at $25.5K.
0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens UBS Group AG's linked filing trail.
Disclosed position value
Top 5
UBS Group AG
$25.5K
TWO SIGMA SECURITIES, LLC
$11.6K
GEODE CAPITAL MANAGEMENT, LLC
$8.7K
Tower Research Capital LLC (TRC)
$2.5K
OSAIC HOLDINGS, INC.
$120
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$25,495
33,812 shares
|
— | 31 Mar 2025 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
—
denominator unverified
|
$11,572
15,348 shares
|
— | 31 Mar 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$8,673
11,503 shares
|
— | 31 Mar 2025 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
—
denominator unverified
|
$2,510
3,329 shares
|
— | 31 Mar 2025 |
| OSAIC HOLDINGS, INC. |
13F
Company
|
—
denominator unverified
|
$120
162 shares
|
— | 31 Mar 2025 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
—
denominator unverified
|
$9
12 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
14
Shares
116,491
Rows available
14
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q2 2025 holders
14
Holder diff
13
| Investor | Q3 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend